Unknown

Dataset Information

0

Targeting proximal tubule mitochondrial dysfunction attenuates the renal disease of methylmalonic acidemia.


ABSTRACT: Isolated methylmalonic acidemia (MMA), caused by deficiency of the mitochondrial enzyme methylmalonyl-CoA mutase (MUT), is often complicated by end stage renal disease that is resistant to conventional therapies, including liver transplantation. To establish a viable model of MMA renal disease, Mut was expressed in the liver of Mut(-/-) mice as a stable transgene under the control of an albumin (INS-Alb-Mut) promoter. Mut(-/-);Tg(INS-Alb-Mut) mice, although completely rescued from neonatal lethality that was displayed by Mut(-/-) mice, manifested a decreased glomerular filtration rate (GFR), chronic tubulointerstitial nephritis and ultrastructural changes in the proximal tubule mitochondria associated with aberrant tubular function, as demonstrated by single-nephron GFR studies. Microarray analysis of Mut(-/-);Tg(INS-Alb-Mut) kidneys identified numerous biomarkers, including lipocalin-2, which was then used to monitor the response of the GFR to antioxidant therapy in the mouse model. Renal biopsies and biomarker analysis from a large and diverse patient cohort (ClinicalTrials.gov identifier: NCT00078078) precisely replicated the findings in the animals, establishing Mut(-/-);Tg(INS-Alb-Mut) mice as a unique model of MMA renal disease. Our studies suggest proximal tubular mitochondrial dysfunction is a key pathogenic mechanism of MMA-associated kidney disease, identify lipocalin-2 as a biomarker of increased oxidative stress in the renal tubule, and demonstrate that antioxidants can attenuate the renal disease of MMA.

SUBMITTER: Manoli I 

PROVIDER: S-EPMC3746875 | biostudies-literature | 2013 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications


Isolated methylmalonic acidemia (MMA), caused by deficiency of the mitochondrial enzyme methylmalonyl-CoA mutase (MUT), is often complicated by end stage renal disease that is resistant to conventional therapies, including liver transplantation. To establish a viable model of MMA renal disease, Mut was expressed in the liver of Mut(-/-) mice as a stable transgene under the control of an albumin (INS-Alb-Mut) promoter. Mut(-/-);Tg(INS-Alb-Mut) mice, although completely rescued from neonatal letha  ...[more]

Similar Datasets

2013-05-01 | GSE41044 | GEO
| S-EPMC2660647 | biostudies-literature
| S-EPMC8558192 | biostudies-literature
| S-EPMC4149057 | biostudies-literature
| S-EPMC5587643 | biostudies-literature
2023-04-18 | GSE225545 | GEO
| S-EPMC8120835 | biostudies-literature
| S-EPMC8569378 | biostudies-literature
| S-EPMC3943540 | biostudies-literature
| S-EPMC10799514 | biostudies-literature